Literature DB >> 18599512

Notch signalling is required for both dauer maintenance and recovery in C. elegans.

Jimmy Ouellet1, Shaolin Li, Richard Roy.   

Abstract

The Notch signalling pathway is conserved among higher metazoans and is used repeatedly throughout development to specify distinct cell fates among populations of equipotent cells. Mounting evidence suggests that Notch signalling may also be crucial in neuronal function in postmitotic, differentiated neurons. Here, we demonstrate a novel role for the canonical Notch signalling pathway in postmitotic neurons during a specialised ;diapause-like' post-embryonic developmental stage in C. elegans called dauer. Our data suggest that cell signalling downstream of the developmental decision to enter dauer leads to the activation of Notch-responding genes in postmitotic neurons. Consistent with this, we demonstrate that glp-1, one of the two C. elegans Notch receptors, and its ligand lag-2 are expressed in neurons during the dauer stage, and both genes are required to maintain this stage in a daf-7/TGFbeta dauer constitutive background. Our genetic data also suggest that a second Notch receptor, lin-12, functions upstream of, or in parallel with, insulin-like signalling components in response to replete growth conditions to promote dauer recovery. Based on our findings, cues associated with the onset of dauer ultimately trigger a glp-1-dependent Notch signalling cascade in neurons to maintain this developmental state. Then, as growth conditions improve, activation of the LIN-12 Notch receptor cooperates with the insulin-like signalling pathway to signal recovery from the dauer stage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599512     DOI: 10.1242/dev.012435

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  24 in total

1.  The LIM and POU homeobox genes ttx-3 and unc-86 act as terminal selectors in distinct cholinergic and serotonergic neuron types.

Authors:  Feifan Zhang; Abhishek Bhattacharya; Jessica C Nelson; Namiko Abe; Patricia Gordon; Carla Lloret-Fernandez; Miren Maicas; Nuria Flames; Richard S Mann; Daniel A Colón-Ramos; Oliver Hobert
Journal:  Development       Date:  2013-12-18       Impact factor: 6.868

Review 2.  TGF-β signaling in C. elegans.

Authors:  Tina L Gumienny; Cathy Savage-Dunn
Journal:  WormBook       Date:  2013-07-10

3.  In vivo imaging of Dauer-specific neuronal remodeling in C. elegans.

Authors:  Nathan E Schroeder; Kristen M Flatt
Journal:  J Vis Exp       Date:  2014-09-04       Impact factor: 1.355

Review 4.  Working with dauer larvae.

Authors:  Xantha Karp
Journal:  WormBook       Date:  2018-08-09

5.  Developmental and Cell Cycle Quiescence Is Mediated by the Nuclear Hormone Receptor Coregulator DIN-1S in the Caenorhabditis elegans Dauer Larva.

Authors:  Eileen Colella; Shaolin Li; Richard Roy
Journal:  Genetics       Date:  2016-06-03       Impact factor: 4.562

6.  Linking the environment, DAF-7/TGFβ signaling and LAG-2/DSL ligand expression in the germline stem cell niche.

Authors:  Olga Pekar; Maria C Ow; Kailyn Y Hui; Marcus B Noyes; Sarah E Hall; E Jane Albert Hubbard
Journal:  Development       Date:  2017-08-15       Impact factor: 6.868

7.  Insulin signaling promotes germline proliferation in C. elegans.

Authors:  David Michaelson; Dorota Z Korta; Yossi Capua; E Jane Albert Hubbard
Journal:  Development       Date:  2010-02       Impact factor: 6.868

8.  Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway.

Authors:  S Eliasz; S Liang; Y Chen; M A De Marco; O Machek; S Skucha; L Miele; M Bocchetta
Journal:  Oncogene       Date:  2010-02-15       Impact factor: 9.867

Review 9.  Sensory systems: their impact on C. elegans survival.

Authors:  Erika Allen; Jing Ren; Yun Zhang; Joy Alcedo
Journal:  Neuroscience       Date:  2014-07-02       Impact factor: 3.590

10.  The DSL ligand APX-1 is required for normal ovulation in C. elegans.

Authors:  Marie McGovern; Perla Gisela Castaneda; Olga Pekar; Laura G Vallier; Erin J Cram; E Jane Albert Hubbard
Journal:  Dev Biol       Date:  2018-01-31       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.